[Lung cancer screening with low dose computed tomography : a systematic review]. / Dépistage du cancer bronchique par tomodensitométrie à faible dose : une revue systématique des essais contrôlés randomisés.
Rev Mal Respir
; 38(5): 489-505, 2021 May.
Article
in Fr
| MEDLINE
| ID: mdl-33994043
ABSTRACT
INTRODUCTION:
Bronchial cancer, often diagnosed at a late stage, is the leading cause of cancer death. As early detection could potentially lead to curative treatment, several studies have evaluated low-dose chest CT (LDCT) as a screening method. The main objective of this work is to determine the impact of LDCT screening on overall mortality of a smoking population.METHODS:
Systematic review of randomised controlled screening trials comparing LDCT with no screening or chest x-ray.RESULTS:
Thirteen randomised controlled trials were identified, seven of which reported mortality results. NSLT showed a significant reduction of 6.7% in overall mortality and 20% in lung cancer mortality after 6.5 years of follow-up. NELSON showed a significant reduction in lung cancer mortality of 24% at 10 years among men. LUSI and MILD showed a reduction in lung cancer mortality of 69% at 8 years among women and 39% at 10 years, respectively.CONCLUSION:
Screening for bronchial cancer is a complex issue. Clarification is needed regarding the selection of individuals, the definition of a positive result and the attitude towards a suspicious nodule.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Early Detection of Cancer
/
Lung Neoplasms
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Screening_studies
/
Systematic_reviews
Limits:
Female
/
Humans
/
Male
Language:
Fr
Journal:
Rev Mal Respir
Year:
2021
Document type:
Article